Armata Pharmaceuticals (NYSE:ARMP) said its inhaled bacterial infection drug for lung disorder was well-tolerated with a treatment emergent adverse event (TEAE) profile similar to placebo in a phase ...

The Armata is a new-generation tank. It is a clean sheet design with a number of advanced features. It has little in common with the current T-90 and other older Soviet tanks. Actually it it the first ...

The engine designed for Russia’s T-14 Armata tank has faced delays, redesigns, and conflicting reports about performance. Development challenges highlight how propulsion systems remain one of the most ...

For more than a year and a half, heavy sanctions imposed by the U.S. and its North Atlantic Treaty Organization (NATO) allies have unquestionably hit Russia’s defense sector. Without the materials and ...

Summary: The T-14 Armata tank, unveiled in 2015, was intended to be a revolutionary advancement in armored warfare. -Featuring an unmanned turret, advanced armor, and a new 125mm smoothbore cannon, it ...

Armata Pharmaceuticals ( ARMP) announced Thursday that it has closed the second and final tranche of its previously announced private placement with Innoviva Strategic Opportunities, a wholly-owned ...

LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on pathogen-specific ...

Here is one diesel vehicle nobody will be testing for emissions: the Armata T-14 main battle tank, a fifth generation of Russia's primary armoured fighting vehicle. There are a lot of noteworthy ...

Proceeds to be used to continue to advance development of Armata's phage product candidates Proceeds from the new financing transaction will be used to advance the Company's lead therapeutic phage ...